New Beacon Discovery Makes Single-Cell Analysis More Accessible
A Compact Benchtop Optofluidic System with Lower Cost of Ownership for Broader Research Accessibility
Bruker Corporation (Nasdaq: BRKR) today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This new Beacon benchtop system offers an accessible entry point into live single-cell functional analysis.
Beacon Discovery – an accessible, compact system for live single-cell functional analysis
Building on Bruker’s proprietary Opto-Electrical Positioning (OEP) technology and scalable OptoSelect™ microfluidic…
